Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Clinton F Stewart

Showing results (51-60 of 220) with videos related to

Pageof 22
Sort By:
Mathematical Biosciences|October 7, 2003
A mechanistic mathematical model of temozolomide myelosuppression in children with high-grade gliomasJohn Carl Panetta, Mark N Kirstein, A J Gajjar, et al.
Biomedical Chromatography : BMC|October 8, 2009
Determination of dopamine, serotonin, and their metabolites in pediatric cerebrospinal fluid by isocratic high performance liquid chromatography coupled with electrochemical detectionK Elaine Hubbard, Amy Wells, Thandranese S Owens, et al.
Journal of Pediatric Hematology/Oncology|September 3, 2004
Topotecan disposition in an anephric childLisa C Iacono, Denise Adams, Alan C Homans, et al.
Cancer Chemotherapy and Pharmacology|October 9, 2017
A physiologically based pharmacokinetic and pharmacodynamic (PBPK/PD) model of the histone deacetylase (HDAC) inhibitor vorinostat for pediatric and adult patients and its application for dose specificationDaniel Moj, Hannah Britz, Jürgen Burhenne, et al.
Pediatric Blood & Cancer|December 1, 2005
Pharmacokinetics and pharmacodynamics of intravenous epoetin alfa in children with cancerBurgess B Freeman, Pamela Hinds, Lisa C Iacono, et al.
Journal of Chromatography. B, Analytical Technologies in the Biomedical and Life Sciences|December 31, 2002
Determination of plasma topotecan and its metabolite N-desmethyl topotecan as both lactone and total form by reversed-phase liquid chromatography with fluorescence detectionFeng Bai, Mark N Kirstein, Suzan K Hanna, et al.
Cancer Chemotherapy and Pharmacology|January 9, 2020
Correction to: Pharmacokinetics and safety of erlotinib and its metabolite OSI-420 in infants and children with primary brain tumorsSamuel J Reddick, Olivia Campagne, Jie Huang, et al.
Cancer|April 25, 2003
Effect of intrapatient dosage escalation of irinotecan on its pharmacokinetics in pediatric patients who have high-grade gliomas and receive enzyme-inducing anticonvulsant therapyAmar Gajjar, Murali M Chintagumpala, Daniel C Bowers, et al.
American Journal of Physiology. Cell Physiology|June 6, 2008
Dexamethasone increases expression and activity of multidrug resistance transporters at the rat blood-brain barrierVishal S Narang, Charles Fraga, Narendra Kumar, et al.
Cancer Chemotherapy and Pharmacology|August 9, 2019
Pharmacokinetics and safety of erlotinib and its metabolite OSI-420 in infants and children with primary brain tumorsSamuel J Reddick, Olivia Campagne, Jie Huang, et al.
Pageof 22

Showing results (51-60 of 220) with videos related to

Sort By:
Pageof 22
Mathematical Biosciences|October 7, 2003
A mechanistic mathematical model of temozolomide myelosuppression in children with high-grade gliomasJohn Carl Panetta, Mark N Kirstein, A J Gajjar, et al.
Biomedical Chromatography : BMC|October 8, 2009
Determination of dopamine, serotonin, and their metabolites in pediatric cerebrospinal fluid by isocratic high performance liquid chromatography coupled with electrochemical detectionK Elaine Hubbard, Amy Wells, Thandranese S Owens, et al.
Journal of Pediatric Hematology/Oncology|September 3, 2004
Topotecan disposition in an anephric childLisa C Iacono, Denise Adams, Alan C Homans, et al.
Cancer Chemotherapy and Pharmacology|October 9, 2017
A physiologically based pharmacokinetic and pharmacodynamic (PBPK/PD) model of the histone deacetylase (HDAC) inhibitor vorinostat for pediatric and adult patients and its application for dose specificationDaniel Moj, Hannah Britz, Jürgen Burhenne, et al.
Pediatric Blood & Cancer|December 1, 2005
Pharmacokinetics and pharmacodynamics of intravenous epoetin alfa in children with cancerBurgess B Freeman, Pamela Hinds, Lisa C Iacono, et al.
Journal of Chromatography. B, Analytical Technologies in the Biomedical and Life Sciences|December 31, 2002
Determination of plasma topotecan and its metabolite N-desmethyl topotecan as both lactone and total form by reversed-phase liquid chromatography with fluorescence detectionFeng Bai, Mark N Kirstein, Suzan K Hanna, et al.
Cancer Chemotherapy and Pharmacology|January 9, 2020
Correction to: Pharmacokinetics and safety of erlotinib and its metabolite OSI-420 in infants and children with primary brain tumorsSamuel J Reddick, Olivia Campagne, Jie Huang, et al.
Cancer|April 25, 2003
Effect of intrapatient dosage escalation of irinotecan on its pharmacokinetics in pediatric patients who have high-grade gliomas and receive enzyme-inducing anticonvulsant therapyAmar Gajjar, Murali M Chintagumpala, Daniel C Bowers, et al.
American Journal of Physiology. Cell Physiology|June 6, 2008
Dexamethasone increases expression and activity of multidrug resistance transporters at the rat blood-brain barrierVishal S Narang, Charles Fraga, Narendra Kumar, et al.
Cancer Chemotherapy and Pharmacology|August 9, 2019
Pharmacokinetics and safety of erlotinib and its metabolite OSI-420 in infants and children with primary brain tumorsSamuel J Reddick, Olivia Campagne, Jie Huang, et al.
Pageof 22